ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

UK COVID-19 variant has significantly higher death rate: study

Highly infectious new type detected last year has spread around the world

Medical workers move a patient outside of the Royal London Hospital: The COVID-19 variant found in Britain late last year is between 30% and 100% more deadly than previous variants.   © Reuters

LONDON (Reuters) -- A highly infectious variant of COVID-19 that has spread around the world since it was first discovered in Britain late last year is between 30% and 100% more deadly than previous dominant variants, researchers said on Wednesday.

In a study that compared death rates among people in Britain infected with the new SARS-CoV-2 variant - known as B.1.1.7 - against those infected with other variants of the COVID-19-causing virus, scientists said the new variant's mortality rate was "significantly higher".

The B.1.1.7 variant was first detected in Britain in September 2020, and has since also been found in more than 100 other countries.

It has 23 mutations in its genetic code - a relatively high number - and some of them have made it far more easily spread. Scientists say it is about 40%-70% more transmissible than previous dominant variants that were circulating.

In the UK study, published in the British Medical Journal on Wednesday, infection with the new variant led to 227 deaths in a sample of 54,906 COVID-19 patients, compared with 141 among the same number of patients infected with other variants.

"Coupled with its ability to spread rapidly, this makes B.1.1.7 a threat that should be taken seriously," said Robert Challen, a researcher at Exeter University who co-led the research.

Independent experts said this study's findings add to previous preliminary evidence linking infection with the B.1.1.7 virus variant with an increased risk of dying from COVID-19.

Initial findings from the study were presented to the UK government earlier this year, along with other research, by experts on its New and Emerging Respiratory Virus Threats Advisory Group, or NERVTAG, panel.

Lawrence Young, a virologist and professor of molecular oncology at Warwick University, said the precise mechanisms behind the higher death rate of the B.1.1.7 variant were still not clear, but "could be related to higher levels of virus replication as well as increased transmissibility".

He warned that the UK variant was likely fuelling a recent surge in infections across Europe.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more